126 related articles for article (PubMed ID: 9195398)
1. Increased prevalence of Helicobacter pylori infection among patients affected with intestinal-type gastric cancer at non-cardiac locations.
Wu MS; Chen SY; Shun CT; Lee WJ; Wang HP; Wang TH; Chen CJ; Lin JT
J Gastroenterol Hepatol; 1997 Jun; 12(6):425-8. PubMed ID: 9195398
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer.
Hansson LR; Engstrand L; Nyrén O; Lindgren A
Gastroenterology; 1995 Sep; 109(3):885-8. PubMed ID: 7657118
[TBL] [Abstract][Full Text] [Related]
3. Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori.
Martín-de-Argila C; Boixeda D; Redondo C; Alvarez I; Gisbert JP; García Plaza A; Cantón R
Scand J Gastroenterol; 1997 Apr; 32(4):303-7. PubMed ID: 9140150
[TBL] [Abstract][Full Text] [Related]
4. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
[TBL] [Abstract][Full Text] [Related]
5. Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence.
Rudi J; Müller M; von Herbay A; Zuna I; Raedsch R; Stremmel W; Räth U
Scand J Gastroenterol; 1995 Oct; 30(10):958-63. PubMed ID: 8545615
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period.
Knekt P; Teppo L; Aromaa A; Rissanen H; Kosunen TU
Int J Cancer; 2006 Aug; 119(3):702-5. PubMed ID: 16496404
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China.
Limburg P; Qiao Y; Mark S; Wang G; Perez-Perez G; Blaser M; Wu Y; Zou X; Dong Z; Taylor P; Dawsey S
J Natl Cancer Inst; 2001 Feb; 93(3):226-33. PubMed ID: 11158192
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
[TBL] [Abstract][Full Text] [Related]
9. [Helicobacter pylori infection and gastric cardia cancer: a nested case-control study].
Ren JS; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):428-31. PubMed ID: 19024516
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
[TBL] [Abstract][Full Text] [Related]
11. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
12. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Helicobacter pylori infection and the prevalence, site and histological type of gastric cancer.
Kato M; Asaka M; Shimizu Y; Nobuta A; Takeda H; Sugiyama T;
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():85-9. PubMed ID: 15298611
[TBL] [Abstract][Full Text] [Related]
14. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
16. Gastric adenocarcinoma and Helicobacter pylori infection.
Talley NJ; Zinsmeister AR; Weaver A; DiMagno EP; Carpenter HA; Perez-Perez GI; Blaser MJ
J Natl Cancer Inst; 1991 Dec; 83(23):1734-9. PubMed ID: 1770552
[TBL] [Abstract][Full Text] [Related]
17. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
Ławniczak M; Starzyńska T
Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Helicobacter pylori infection and intestinal metaplasia in subjects who had undergone surgery for gastric adenocarcinoma in Northwest Italy.
Palestro G; Pellicano R; Fronda GR; Valente G; De Giuli M; Soldati T; Pugliese A; Taraglio S; Garino M; Campra D; Cutufia MA; Margaria E; Spinzi G; Ferrara A; Marenco G; Rizzetto M; Ponzetto A
World J Gastroenterol; 2005 Dec; 11(45):7131-5. PubMed ID: 16437659
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH
Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
